Why do people develop antibodies to food? While clinicians have long observed that healthy humans develop a particular type ...

Calliditas Therapeutics (Calliditas), an Asahi Kasei company, announced today that new data was presented at the 62nd European Renal Association Congress (ERA Congress), which took place in Vienna, ...

Pfizer's CEO discussed the extensive due diligence the company has conducted on the 3SBio PD-1xVEGF deal. | Pfizer's CEO ...

Sibeprenlimab clinically reduces proteinuria in adults with immunoglobulin A nephropathy (IgAN), according to data from a prespecified analysis of the phase 3 VISIONARY trial. The findings were ...

Otsuka Pharmaceutical has shared positive results from a late-stage study of its investigational monoclonal antibody ...

Travere Therapeutics today announced that the Company will present three abstracts at the upcoming International Podocyte Conference.

The appendix may play a further role in protecting the gastrointestinal system from invading pathogens. This would explain ...

Blood Plasma Derivatives Market Research Report Information By Type, By Application, And By Geography. NY, UNITED STATES, June 11, 2025 /EINPresswire.com/ -- Blood Plasma Derivati ...

Given the probability of trial success and current valuation, we rate the ATYR stock 'Hold' as risk and reward appear ...